A citation-based method for searching scientific literature

Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks, Christopher Kennard, David Craufurd, Chris Frost, Douglas R Langbehn, Ralf Reilmann, Julie C Stout. Lancet Neurol 2011
Times Cited: 377







List of co-cited articles
1106 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
624
58

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
346
41

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
474
40



Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
526
30

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
509
25

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
162
21

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
19

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
535
18

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
876
17

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Marina Papoutsi, G Bernhard Landwehrmeyer,[...]. EBioMedicine 2015
78
19

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
515
15

White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Louisa Salmon, Andrew Churchyard, Phyllis Chua, Nellie Georgiou-Karistianis, Gary F Egan. Neurobiol Dis 2014
62
24

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
246
15

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
460
15

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
137
14


Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
233
14

Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.
Nellie Georgiou-Karistianis, Rachael Scahill, Sarah J Tabrizi, Ferdinando Squitieri, Elizabeth Aylward. Neurosci Biobehav Rev 2013
57
22

Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
Peter McColgan, Kiran K Seunarine, Adeel Razi, James H Cole, Sarah Gregory, Alexandra Durr, Raymund A C Roos, Julie C Stout, Bernhard Landwehrmeyer, Rachael I Scahill,[...]. Brain 2015
50
24

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
396
12

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
138
12

Onset and rate of striatal atrophy in preclinical Huntington disease.
E H Aylward, B F Sparks, K M Field, V Yallapragada, B D Shpritz, A Rosenblatt, J Brandt, L M Gourley, K Liang, H Zhou,[...]. Neurology 2004
285
12

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
H Diana Rosas, David S Tuch, Nathanael D Hevelone, Alexandra K Zaleta, Mark Vangel, Steven M Hersch, David H Salat. Mov Disord 2006
240
12

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
163
12

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
59
20

Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
240
12

Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.
Eve M Dumas, Simon J A van den Bogaard, Margot E Ruber, Ralf R Reilman, Julie C Stout, David Craufurd, Stephen L Hicks, Chris Kennard, Sarah J Tabrizi, Mark A van Buchem,[...]. Hum Brain Mapp 2012
93
11

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
H Diana Rosas, Stephanie Y Lee, Alexander C Bender, Alexandra K Zaleta, Mark Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina Onorato, Jang-Ho Cha,[...]. Neuroimage 2010
177
11

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
314
11

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.
H D Rosas, W J Koroshetz, Y I Chen, C Skeuse, M Vangel, M E Cudkowicz, K Caplan, K Marek, L J Seidman, N Makris,[...]. Neurology 2003
365
11

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Andrew Churchyard, Phyllis Chua, Gary F Egan, Nellie Georgiou-Karistianis. Neurobiol Dis 2015
56
19

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
143
10

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Julie C Stout, Rebecca Jones, Izelle Labuschagne, Alison M O'Regan, Miranda J Say, Eve M Dumas, Sarah Queller, Damian Justo, Rachelle Dar Santos, Allison Coleman,[...]. J Neurol Neurosurg Psychiatry 2012
89
11

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
336
10

Linking white matter and deep gray matter alterations in premanifest Huntington disease.
Andreia V Faria, J Tilak Ratnanather, Daniel J Tward, David Soobin Lee, Frieda van den Noort, Dan Wu, Timothy Brown, Hans Johnson, Jane S Paulsen, Christopher A Ross,[...]. Neuroimage Clin 2016
33
30

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
128
10

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
G Douaud, V Gaura, M-J Ribeiro, F Lethimonnier, R Maroy, C Verny, P Krystkowiak, P Damier, A-C Bachoud-Levi, P Hantraye,[...]. Neuroimage 2006
182
10

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
224
10

Brain structure in preclinical Huntington's disease.
Jane S Paulsen, Vince A Magnotta, Ania E Mikos, Henry L Paulson, Elizabeth Penziner, Nancy C Andreasen, Peg C Nopoulos. Biol Psychiatry 2006
170
10

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.
Peter McColgan, Sarah Gregory, Kiran K Seunarine, Adeel Razi, Marina Papoutsi, Eileanoir Johnson, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Peter Holmans,[...]. Biol Psychiatry 2018
38
26

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
126
9

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.
Holly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, Curt Mazur, Melissa M McAlonis, Kimberly A Pytel, Jonathan W Artates, Andreas Weiss, Seng H Cheng, Lamya S Shihabuddin,[...]. Neuron 2012
442
9

Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Edward J Wild, Roberto Boggio, Douglas Langbehn, Nicola Robertson, Salman Haider, James R C Miller, Henrik Zetterberg, Blair R Leavitt, Rainer Kuhn, Sarah J Tabrizi,[...]. J Clin Invest 2015
115
9

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
9

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
201
9

Regional and progressive thinning of the cortical ribbon in Huntington's disease.
H D Rosas, A K Liu, S Hersch, M Glessner, R J Ferrante, D H Salat, A van der Kouwe, B G Jenkins, A M Dale, B Fischl. Neurology 2002
770
9

Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study.
M A Gray, G F Egan, A Ando, A Churchyard, P Chua, J C Stout, N Georgiou-Karistianis. Exp Neurol 2013
70
12

Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Nellie Georgiou-Karistianis, Govinda R Poudel, Juan F Domínguez D, Rebecca Langmaid, Marcus A Gray, Andrew Churchyard, Phyllis Chua, Beth Borowsky, Gary F Egan, Julie C Stout. Brain Cogn 2013
41
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.